
Hormone Therapy for Prostate Cancer Fact Sheet - NCI
This fact sheet describes hormone therapy and its role in treating prostate cancer. Learn about the types of hormone therapy, how they are used, and possible side effects.
Hormone therapy for prostate cancer - Mayo Clinic
Jul 15, 2025 · Hormone therapy for prostate cancer is a treatment that lowers or blocks testosterone. This treatment also is called androgen deprivation therapy (ADT). Most prostate …
Hormone Therapy for Prostate Cancer - American Cancer Society
Hormone therapy is also called androgen deprivation therapy (ADT). The goal of this treatment is to reduce levels of male hormones, called androgens, in the body, or to stop them from fueling …
Darolutamide in Combination With Androgen-Deprivation Therapy …
Sep 16, 2024 · Androgen-deprivation therapy (ADT) has been the standard of care for patients with metastatic hormone-sensitive prostate cancer (mHSPC) for decades. 1, 2 However, …
Advanced Treatment Options for Metastatic Prostate Cancer
5 days ago · Foundation of Treatment: Androgen Deprivation Therapy Why Testosterone Matters Prostate cancer cells rely on androgens like testosterone to grow. Androgen deprivation …
Clinical strategies for treating metastatic castration-sensitive ...
Dec 16, 2025 · A recent Urology Times Clinical Forum in Chicago, moderated by Aaron Berger, MD, chief medical officer and director of Clinical Research for Associated Urological …
Androgen Deprivation Therapy for Advanced Prostate Cancer
Feb 3, 2025 · The Consumer’s Guide to Androgen Deprivation Therapy for Advanced Prostate Cancer This type of hormone therapy can help extend the lives of people who have metastatic …
Efficacy and safety evaluation of androgen deprivation therapy …
Sep 2, 2024 · Indirect treatment comparisons of darolutamide plus docetaxel and androgen deprivation therapy in patients with metastatic hormone-sensitive prostate cancer Article
Exploring Androgen Deprivation Therapy in Prostate Cancer
Research in androgen deprivation therapy reveals profound implications for prostate cancer treatment outcomes. The data suggest that ADT can effectively reduce tumor size and …
Darolutamide in Combination With Androgen-Deprivation Therapy …
Sep 16, 2024 · Purpose: For patients with metastatic hormone-sensitive prostate cancer (mHSPC), delaying progression to castration-resistant disease is important not only for overall …